Fluid bolus therapy in pediatric sepsis: a narrative review

Julian San Geroteo1, Michaël Levy2,3, Julien Gotchac4

  • 1Pediatric Intensive Care Unit, Robert-Debré University Hospital, Paris, France. julian.san-geroteo@aphp.fr.

Insights

Pediatric sepsis, a major child killer, requires careful fluid resuscitation. Current guidelines recommend fluid bolus therapy, but the ideal fluid type, especially balanced crystalloids, remains under investigation for pediatric sepsis management.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Resuscitation science

Background:

  • Pediatric sepsis is a leading cause of mortality in children under five globally.
  • Recent guidelines emphasize fluid bolus therapy as a cornerstone in managing pediatric septic shock and organ dysfunction.
  • The optimal fluid choice for resuscitation, particularly balanced crystalloids, is debated due to limited evidence.

Purpose of the Study:

  • To review the current evidence on fluid bolus therapy in pediatric sepsis.
  • To discuss the role and efficacy of balanced crystalloids in pediatric sepsis resuscitation.
  • To highlight the ongoing debate regarding fluid selection in pediatric sepsis management.

Main Methods:

  • Literature review of current evidence on fluid resuscitation in pediatric sepsis.
  • Analysis of Surviving Sepsis Campaign guidelines (2020) regarding pediatric sepsis management.
  • Discussion of theoretical benefits and clinical data on balanced crystalloids versus other fluid options.

Main Results:

  • Fluid bolus therapy is a critical component of pediatric sepsis management.
  • Balanced crystalloids are proposed as potentially beneficial, but evidence in pediatrics is limited and debated.
  • Adult data on fluid choice in sepsis are not consistently applicable to pediatric populations.

Conclusions:

  • Further high-quality research is needed to establish the optimal fluid for pediatric sepsis resuscitation.
  • The use of balanced crystalloids in pediatric sepsis requires more investigation to clarify their benefits and risks.
  • Clinical practice regarding fluid selection in pediatric sepsis should consider the evolving evidence and ongoing expert discussion.

Related Concept Videos

One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
283
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
654
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
426
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
124
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
30